- Home
- CCM vs GDTC Comparison
CCM vs GDTC Comparison
Compare CCM & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- GDTC
- Stock Information
- Founded
- CCM 1997
- GDTC 2018
- Country
- CCM China
- GDTC Singapore
- Employees
- CCM N/A
- GDTC N/A
- Industry
- CCM Medical/Nursing Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- GDTC Health Care
- Exchange
- CCM Nasdaq
- GDTC Nasdaq
- Market Cap
- CCM 33.3M
- GDTC 21.5M
- IPO Year
- CCM 2009
- GDTC 2023
- Fundamental
- Price
- CCM $4.96
- GDTC $1.89
- Analyst Decision
- CCM
- GDTC Buy
- Analyst Count
- CCM 0
- GDTC 1
- Target Price
- CCM N/A
- GDTC $5.00
- AVG Volume (30 Days)
- CCM 17.4K
- GDTC 18.1K
- Earning Date
- CCM 09-26-2025
- GDTC 01-01-0001
- Dividend Yield
- CCM N/A
- GDTC N/A
- EPS Growth
- CCM N/A
- GDTC N/A
- EPS
- CCM N/A
- GDTC N/A
- Revenue
- CCM $52,603,198.00
- GDTC $368,838.00
- Revenue This Year
- CCM N/A
- GDTC $5.37
- Revenue Next Year
- CCM N/A
- GDTC N/A
- P/E Ratio
- CCM N/A
- GDTC N/A
- Revenue Growth
- CCM N/A
- GDTC N/A
- 52 Week Low
- CCM $3.80
- GDTC $1.20
- 52 Week High
- CCM $10.77
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- CCM 37.49
- GDTC 37.08
- Support Level
- CCM $5.04
- GDTC $1.85
- Resistance Level
- CCM $5.77
- GDTC $1.95
- Average True Range (ATR)
- CCM 0.91
- GDTC 0.10
- MACD
- CCM -0.01
- GDTC -0.02
- Stochastic Oscillator
- CCM 0.25
- GDTC 28.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.